Knowledge

Alash'le Abimiku

Source 📝

311:. The laboratory, which is containerised with pre-filters to withstand the dry and dusty winds can also assess for extremely drug-resistant TB (XDRTB). It includes a negatively pressurised laboratory that allows for the handling of infectious agents. This laboratory supported the 364:
Research and Development Blueprint. She served as the chair of the board of the African Society of Laboratory Medicine, as well as a member of the board of the Nigerian Institute of Medical Research. She previously served on the
216:
She was one the founders that helped in the establishment of the IHVN Campus project in 2004 with IHVN partnering with the Institute of Human Virology at the University of Maryland School of Medicine in the United States.
805: 319: 718:
Abimiku, Alash'le G.; Croxton, Talishea; Ozumba, Petronilla J.; Agala, Ndidi; Balogun, Olasinbo; Jonathan, Emmanuel; Onyemata, Enzenwa; Ndifon, Kachimi; Nadoma, Sunji; Anazodo, Thankgod; Peters, Sam (2019).
1204: 813: 867: 1209: 172: 54: 334: 249: 245: 947: 210: 148: 82: 1100:"Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors" 639: 1229: 1224: 391:
Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors
341:
is acting to support the move toward local ownership. In 2018 she co-founded the International Research Centre of Excellence located in the
532: 608: 838: 342: 338: 300: 144: 86: 1199: 1194: 875: 308: 296: 292: 337:
transition to a situation where local governments and indigenous organisations are responsible for caring for d individuals. The
557: 345:. The centre will focus on building the capacity of African scientists as well as supporting research that affects the country. 415: 1219: 1214: 323: 640:"IHV and Nigeria Partner with the U.S. to Combat Multi-Drug Resistant Tuberculosis from West Baltimore to West Africa" 972: 220:
Gallo and Abimiku opened the International Center for Scientific Culture—World Laboratory AIDS Research Center in
366: 361: 202: 721:"Blueprint for building a biorepository in a resource-limited setting that follows international best practices" 999: 357: 194: 168: 50: 1024: 507: 228:, she found she had to concentrate on basic screening and community education. Eventually, she studied the 1189: 175:
for her graduate studies, earning a master's degree in 1983 and a PhD in 1998. Here she specialised in
322:(IBSER) repository that can process and store biological samples. The repository was supported by the 1111: 583: 451: 181: 477: 693: 119: 1051:"Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities" 1166: 1139: 1080: 758: 740: 489: 455: 386:
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities
1129: 1119: 1070: 1062: 748: 732: 268:. She has considered the molecular epidemiology and evolution of subtypes and resistance of 668: 441: 244:
studies. In 2004 she helped to establish a partnership with Nigeria using funding from the
143:
is a Nigerian executive director of the International Research Centre of Excellence at the
922: 304: 1115: 584:"Reagent Datasheet Detail: Catalog 3191 - HIV-1 Jv1083 Virus - NIH AIDS Reagent Program" 1134: 1099: 1075: 1050: 753: 720: 370: 327: 897: 1183: 1157:
Abimiku, Alash'le (2012). "Update on HIV-1 diversity in Africa: a decade in review".
561: 176: 65: 776: 284: 261: 257: 241: 198: 164: 1124: 806:"Dr. Alash'le Abimiku receives grant to develop H3 Africa bio repository at IHVN" 326:
Human Heredity and Health in Africa (H3 Africa) program, which was initiated by
265: 237: 205:, where she developed collaborations between scientists in her home country of 307:-3 laboratory, the first of its kind in Africa, to research the prevalence of 744: 493: 459: 948:"Professor Alash'le Abimiku elected Chair of the Board of Directors of ASLM" 1170: 1143: 1084: 762: 369:
HIV vaccine advisory committee and AIDS Vaccine program. She serves on the
736: 99: 1066: 533:"US Varsity, IHVN Launch Research Institute on Healthcare - THISDAYLIVE" 280: 233: 206: 160: 39: 312: 93: 476:
Science, American Association for the Advancement of (28 May 2004).
320:
International Society for Biological and Environmental Repositories
276:
epidemiological studies and the epidemiology of selected viruses.
416:"How HIV positive mothers can breastfeed exclusively —Director |" 694:"Abimiku, Alash'le | University of Maryland School of Medicine" 224:. Whilst Abimiku had planned to isolate a particular strain of 288: 273: 269: 253: 229: 225: 221: 236:; identifying that it was the non-B subtype related to the 151:
who takes interest in the prevention and treatment of HIV.
291:
in the world, which makes them more likely to suffer from
868:"Virology institute establishes research centre in Abuja" 179:
and protection against infection caused by the bacteria
609:"AIDS in Africa: AIDS vaccine 'may not work' in Africa" 396:
Update on HIV-1 diversity in Africa: a decade in review
240:. Abimiku called for African strains to be included in 1025:"Longitudinal Population Studies Committee | Wellcome" 973:"NIMR inaugurates advisory board on research funding" 114: 92: 78: 61: 46: 30: 23: 1000:"ASLM2018 Conference Chair: Prof Alash'le Abimiku" 1205:University of Maryland School of Medicine faculty 443:Protection against Campylobacter jejuni infection 356:Abimiku is a member of the advisory group of the 100:Protection against Campylobacter jejuni infection 299:), an airborne disease. In 2010 Abimiku and the 173:London School of Hygiene & Tropical Medicine 55:London School of Hygiene & Tropical Medicine 193:After earning her doctorate, Abimiku worked as 839:"Spotlight on Prof. Alash'le Abimiku, Nigeria" 8: 373:Longitudinal Population Studies Committee. 256:in disease pathogenesis and the effects of 1210:Fellows of the African Academy of Sciences 246:President's Emergency Plan for AIDS Relief 20: 1133: 1123: 1074: 898:"WHO | Scientific Advisory Group members" 777:"IHVN H3 Africa Biorepository Initiative" 752: 283:are most likely to suffer more from this 211:University of Maryland School of Medicine 149:University of Maryland School of Medicine 83:University of Maryland School of Medicine 979:. The Nation Newspaper. 28 December 2017 406: 725:African Journal of Laboratory Medicine 315:90-90-90 targets and early diagnosis. 861: 859: 833: 831: 800: 798: 7: 633: 631: 629: 558:"Prof. Alash'le Abimiku, Mon – IRCE" 471: 469: 414:Online, The Eagle (10 August 2017). 343:Institute of Human Virology Nigeria 339:Institute of Human Virology Nigeria 301:Institute of Human Virology Nigeria 147:and a professor of virology at the 145:Institute of Human Virology Nigeria 87:Institute of Human Virology Nigeria 14: 293:multi-drug-resistant tuberculosis 272:, the development of cohorts for 440:Abimiku, Alash'le Grace (1988). 333:She has been involved with the 252:). Abimiku studies the role of 1230:Nigerian women medical doctors 1225:Ahmadu Bello University alumni 1: 1055:Clinical Microbiology Reviews 324:National Institutes of Health 318:In 2012 Abimiku developed an 1125:10.1371/journal.pone.0010584 866:Akor, Ojoma (24 July 2018). 232:strain that is prevalent in 1246: 1098:Abimiku, Alash'le (2010). 1049:Abimiku, Alash'le (2011). 638:Abimiku, Alash'le (2010). 381:Her publications include; 1200:Nigerian women biologists 367:World Health Organization 362:World Health Organization 203:National Cancer Institute 110: 71: 1195:Nigerian women academics 923:"WHO | Alash'le Abimiku" 508:"Dr. Alash'le G Abimiku" 155:Early life and education 698:medschool.umaryland.edu 358:University of Cape Town 209:and researchers at the 195:postdoctoral researcher 169:Ahmadu Bello University 51:Ahmadu Bello University 16:Nigerian epidemiologist 141:Alash'le Grace Abimiku 977:thenationonlineng.net 737:10.4102/ajlm.v8i1.722 377:Selected publications 35:Alash'le Grace Abimku 1220:HIV/AIDS researchers 1215:Nigerian virologists 1067:10.1128/CMR.00059-10 452:University of London 182:Campylobacter jejuni 159:Abimiku was born in 1116:2010PLoSO...510584C 673:FAIS Legacy Project 537:www.thisdaylive.com 189:Research and career 171:. She moved to the 669:"Alash'le Abimiku" 878:on 5 October 2019 872:dailytrust.com.ng 816:on 5 October 2019 564:on 5 October 2019 138: 137: 73:Scientific career 1237: 1175: 1174: 1154: 1148: 1147: 1137: 1127: 1095: 1089: 1088: 1078: 1046: 1040: 1039: 1037: 1035: 1021: 1015: 1014: 1012: 1010: 995: 989: 988: 986: 984: 969: 963: 962: 960: 958: 944: 938: 937: 935: 933: 919: 913: 912: 910: 908: 894: 888: 887: 885: 883: 874:. Archived from 863: 854: 853: 851: 849: 835: 826: 825: 823: 821: 812:. Archived from 802: 793: 792: 790: 788: 773: 767: 766: 756: 715: 709: 708: 706: 704: 690: 684: 683: 681: 679: 664: 658: 657: 655: 653: 644: 635: 624: 623: 621: 619: 613:newscientist.com 605: 599: 598: 596: 594: 580: 574: 573: 571: 569: 560:. Archived from 554: 548: 547: 545: 543: 529: 523: 522: 520: 518: 504: 498: 497: 478:"News this Week" 473: 464: 463: 437: 431: 430: 428: 426: 420:The Eagle Online 411: 352:Academic service 134: 131: 130:/Abimiku-Alashle 129: 127: 125: 123: 121: 106: 25:Alash'le Abimiku 21: 1245: 1244: 1240: 1239: 1238: 1236: 1235: 1234: 1180: 1179: 1178: 1156: 1155: 1151: 1097: 1096: 1092: 1048: 1047: 1043: 1033: 1031: 1023: 1022: 1018: 1008: 1006: 997: 996: 992: 982: 980: 971: 970: 966: 956: 954: 946: 945: 941: 931: 929: 921: 920: 916: 906: 904: 896: 895: 891: 881: 879: 865: 864: 857: 847: 845: 837: 836: 829: 819: 817: 804: 803: 796: 786: 784: 783:. 1 August 2013 775: 774: 770: 717: 716: 712: 702: 700: 692: 691: 687: 677: 675: 666: 665: 661: 651: 649: 642: 637: 636: 627: 617: 615: 607: 606: 602: 592: 590: 588:aidsreagent.org 582: 581: 577: 567: 565: 556: 555: 551: 541: 539: 531: 530: 526: 516: 514: 506: 505: 501: 475: 474: 467: 439: 438: 434: 424: 422: 413: 412: 408: 404: 379: 354: 348: 305:Biosafety Level 191: 157: 118: 104: 85: 53: 47:Alma mater 42: 37: 36: 26: 17: 12: 11: 5: 1243: 1241: 1233: 1232: 1227: 1222: 1217: 1212: 1207: 1202: 1197: 1192: 1182: 1181: 1177: 1176: 1149: 1090: 1061:(2): 314–350. 1041: 1029:wellcome.ac.uk 1016: 990: 964: 939: 914: 889: 855: 827: 810:ihvnigeria.org 794: 768: 710: 685: 659: 625: 600: 575: 549: 524: 499: 465: 450:(PhD thesis). 432: 405: 403: 400: 399: 398: 393: 388: 378: 375: 371:Wellcome Trust 353: 350: 328:Charles Rotimi 190: 187: 163:. She studied 156: 153: 136: 135: 116: 112: 111: 108: 107: 96: 90: 89: 80: 76: 75: 69: 68: 63: 62:Known for 59: 58: 48: 44: 43: 38: 34: 32: 28: 27: 24: 15: 13: 10: 9: 6: 4: 3: 2: 1242: 1231: 1228: 1226: 1223: 1221: 1218: 1216: 1213: 1211: 1208: 1206: 1203: 1201: 1198: 1196: 1193: 1191: 1190:Living people 1188: 1187: 1185: 1172: 1168: 1165:(2): 83–100. 1164: 1160: 1153: 1150: 1145: 1141: 1136: 1131: 1126: 1121: 1117: 1113: 1110:(5): e10584. 1109: 1105: 1101: 1094: 1091: 1086: 1082: 1077: 1072: 1068: 1064: 1060: 1056: 1052: 1045: 1042: 1030: 1026: 1020: 1017: 1005: 1001: 998:Admin, ASLM. 994: 991: 978: 974: 968: 965: 953: 949: 943: 940: 928: 924: 918: 915: 903: 899: 893: 890: 877: 873: 869: 862: 860: 856: 844: 840: 834: 832: 828: 815: 811: 807: 801: 799: 795: 782: 778: 772: 769: 764: 760: 755: 750: 746: 742: 738: 734: 730: 726: 722: 714: 711: 699: 695: 689: 686: 674: 670: 663: 660: 648: 641: 634: 632: 630: 626: 614: 610: 604: 601: 589: 585: 579: 576: 563: 559: 553: 550: 538: 534: 528: 525: 513: 509: 503: 500: 495: 491: 488:(5675): 180. 487: 483: 479: 472: 470: 466: 461: 457: 453: 449: 445: 444: 436: 433: 421: 417: 410: 407: 401: 397: 394: 392: 389: 387: 384: 383: 382: 376: 374: 372: 368: 363: 359: 351: 349: 346: 344: 340: 336: 331: 329: 325: 321: 316: 314: 310: 306: 302: 298: 294: 290: 286: 282: 277: 275: 271: 267: 263: 259: 255: 251: 247: 243: 239: 238:HIV subtype G 235: 231: 227: 223: 218: 214: 212: 208: 204: 200: 196: 188: 186: 184: 183: 178: 177:retrovirology 174: 170: 166: 162: 154: 152: 150: 146: 142: 133: 117: 113: 109: 102: 101: 97: 95: 91: 88: 84: 81: 77: 74: 70: 67: 66:Retrovirology 64: 60: 56: 52: 49: 45: 41: 33: 29: 22: 19: 1162: 1158: 1152: 1107: 1103: 1093: 1058: 1054: 1044: 1032:. Retrieved 1028: 1019: 1007:. Retrieved 1003: 993: 981:. Retrieved 976: 967: 955:. Retrieved 951: 942: 930:. Retrieved 926: 917: 905:. Retrieved 901: 892: 880:. Retrieved 876:the original 871: 846:. Retrieved 842: 818:. Retrieved 814:the original 809: 785:. Retrieved 780: 771: 728: 724: 713: 701:. Retrieved 697: 688: 676:. Retrieved 672: 662: 650:. Retrieved 646: 616:. Retrieved 612: 603: 591:. Retrieved 587: 578: 566:. Retrieved 562:the original 552: 540:. Retrieved 536: 527: 515:. Retrieved 511: 502: 485: 481: 448:london.ac.uk 447: 442: 435: 423:. Retrieved 419: 409: 395: 390: 385: 380: 355: 347: 332: 317: 278: 266:co-infection 258:tuberculosis 242:AIDS Vaccine 219: 215: 199:Robert Gallo 192: 180: 165:microbiology 158: 140: 139: 98: 79:Institutions 72: 18: 1159:AIDS Review 1184:Categories 542:7 November 425:7 November 402:References 279:People in 264:) and HIV 124:.umaryland 122:.medschool 1034:5 October 1009:5 October 983:5 October 957:5 October 932:5 October 907:5 October 882:5 October 848:5 October 820:5 October 745:2225-2010 731:(1): 12. 703:5 October 678:5 October 652:5 January 618:5 October 593:5 October 568:5 October 517:5 October 494:0036-8075 460:940318607 303:opened a 128:/profiles 1171:22627605 1144:20485670 1104:PLOS ONE 1085:21482728 1004:ASLM2018 781:Grantome 763:31534913 667:bonbon. 512:H3Africa 360:and the 1135:2868044 1112:Bibcode 1076:3122496 927:who.int 902:who.int 787:26 June 754:6739520 482:Science 281:Nigeria 234:Nigeria 207:Nigeria 201:at the 161:Nigeria 115:Website 40:Nigeria 1169:  1142:  1132:  1083:  1073:  761:  751:  743:  492:  458:  335:PEPFAR 313:UNAIDS 309:MDR-TB 297:MDR-TB 250:PEPFAR 105:(1988) 103:  94:Thesis 643:(PDF) 197:with 57:(PhD) 1167:PMID 1140:PMID 1081:PMID 1036:2019 1011:2019 985:2019 959:2019 952:ASLM 934:2019 909:2019 884:2019 850:2019 843:ASLM 822:2019 789:2024 759:PMID 741:ISSN 705:2019 680:2019 654:2019 620:2019 595:2019 570:2019 544:2023 519:2019 490:ISSN 456:OCLC 427:2023 287:and 167:at 126:.edu 31:Born 1130:PMC 1120:doi 1071:PMC 1063:doi 749:PMC 733:doi 647:IHV 486:304 289:HIV 274:HIV 270:HIV 254:HIV 230:HIV 226:HIV 222:Jos 120:www 1186:: 1163:14 1161:. 1138:. 1128:. 1118:. 1106:. 1102:. 1079:. 1069:. 1059:24 1057:. 1053:. 1027:. 1002:. 975:. 950:. 925:. 900:. 870:. 858:^ 841:. 830:^ 808:. 797:^ 779:. 757:. 747:. 739:. 727:. 723:. 696:. 671:. 645:. 628:^ 611:. 586:. 535:. 510:. 484:. 480:. 468:^ 454:. 446:. 418:. 330:. 285:TB 262:TB 213:. 185:. 1173:. 1146:. 1122:: 1114:: 1108:5 1087:. 1065:: 1038:. 1013:. 987:. 961:. 936:. 911:. 886:. 852:. 824:. 791:. 765:. 735:: 729:8 707:. 682:. 656:. 622:. 597:. 572:. 546:. 521:. 496:. 462:. 429:. 295:( 260:( 248:( 132:/

Index

Nigeria
Ahmadu Bello University
London School of Hygiene & Tropical Medicine
Retrovirology
University of Maryland School of Medicine
Institute of Human Virology Nigeria
Thesis
Protection against Campylobacter jejuni infection
www.medschool.umaryland.edu/profiles/Abimiku-Alashle/
Institute of Human Virology Nigeria
University of Maryland School of Medicine
Nigeria
microbiology
Ahmadu Bello University
London School of Hygiene & Tropical Medicine
retrovirology
Campylobacter jejuni
postdoctoral researcher
Robert Gallo
National Cancer Institute
Nigeria
University of Maryland School of Medicine
Jos
HIV
HIV
Nigeria
HIV subtype G
AIDS Vaccine
President's Emergency Plan for AIDS Relief
PEPFAR

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.